People: Altimmune Inc (ALT.OQ)

ALT.OQ on NASDAQ Stock Exchange Global Market

12:23am IST
Change (% chg)

$0.01 (+0.57%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Gill, John 

Mr. John M. Gill serves as Director of the Company. Mr. Gill served as PharmAthene’s President and Chief Executive Officer from March 2015 until the completion of the Merger in May 2017. From 2003 to 2013, Mr. Gill served as the President, Chief Executive Officer, co-founder and a Director of TetraLogic Pharmaceuticals Corporation, a public biopharmaceutical company. Mr. Gill has previously held positions at 3-Dimensional Pharmaceuticals and SmithKline Beecham. After serving in the United States Marine Corps, Mr. Gill earned a B.A. from Rutgers University. We believe Mr. Gill’s executive and board experience in the pharmaceutical industry and his substantial financial knowledge and expertise make him well qualified to serve as a member of our Board of Directors.

Basic Compensation

Total Annual Compensation, USD 409,962
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 82,273
Fiscal Year Total, USD 492,235

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --